Tag: survival

VRK1: A protein that reduces the survival of patients with neuroblastoma

Researchers from the Departments of Cell Biology and Medical Physiology at the University of Seville have identified that a high expression of the human protein VRK1 is associated with tumor aggressiveness and low survival among neuroblastoma patients. Aggressive neuroblastoma is one of the most common solid childhood cancers and causes disproportionately high mortality in affected

ASH: Black Race Linked to Poorer Survival in AML

TUESDAY, Dec. 8, 2020 — Self-reported patient race is the most important factor associated with poorer survival in patients with acute myeloid leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology, held virtually from Dec. 5 to 8. Bhavana Bhatnagar, D.O., from The Ohio State University Comprehensive

Cervical cancer: New radiotherapy technique prolongs survival

Patients with locally advanced cervical cancer benefit significantly from an innovative radiotherapy technique co-developed by MedUni Vienna under the direction of Richard Pötter and Christian Kirisits. The technique provides better tumor control and produces fewer side-effects. This is substantiated by the results of the prospective, international, multi-center study, EMBRACE I, conducted under the direction of

Scientists uncover proteins essential for memory B cell survival

Signals from two key proteins are essential for the survival of our ‘immunological memory’, according to new research from scientists at the Francis Crick Institute, published in the Journal of Experimental Medicine. Memory B cells are long-lived cells that confer immunological memory by providing rapid and robust antibody responses to infections our body has seen

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 15 in Cancer Medicine. Neela L. Penumarthy, M.D., from Seattle Children’s Hospital, and colleagues used data from the University of California San Francisco Cancer Registry to identify patients

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

Researchers from The University of Texas MD Anderson Cancer Center today reported results from a pooled analysis of more than 5,100 breast cancer patients that found residual cancer burden (RCB) continuous index and classification were independently and strongly prognostic for all breast cancer phenotypes. The study’s results were presented by W. Fraser Symmans, M.D., professor

Metabolic adaptation ensures survival of colon cancer cells

Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from

Air pollution slashes survival chances for heart transplant patients

Air pollution slashes the survival chances for heart transplant patients, finds study Experts at Case Western Reserve University in Ohio tracked 22,000 people All of the patients had received a donor heart between 2004 and 2015  They compared patients’ home address against levels of PM2.5 pollution  Air pollution slashes the survival chances for people who

Radiation plus chemotherapy doesn’t improve endometrial cancer recurrence-free survival

The standard of care for women with stage III/IVA endometrial cancer following surgery has been chemotherapy and radiation to prevent recurrence. But in a surprising new finding, radiation combined with chemotherapy did not increase recurrence-free survival in these women, reports a National Cancer Institute-sponsored Gynecology Oncology Group study led by a Northwestern Medicine scientist/physician. This

Medicaid Expansion Tied to Better Kidney Disease Survival

TUESDAY, Nov. 6, 2018 — There were significant improvements in one-year survival among patients with end-stage renal disease (ESRD) initiating dialysis following Medicaid expansion with the Affordable Care Act, according to a study published online Oct. 25 in the Journal of the American Medical Association. Shailender Swaminathan, Ph.D., from the Brown University School of Public

Treatment tied to survival benefit in complex bladder cancer

(HealthDay)—Cancer treatment is associated with a clinically meaningful survival benefit in older, medically complex patients with superficial bladder cancer (SBC), according to a study published online Oct. 5 in Cancer. Tullika Garg, M.D., M.P.H., from Geisinger in Danville, Pa., and colleagues evaluated the association between treatment of SBC and 10-year mortality in 1,800 medically complex